Clinical experience with the cervista HPV HR assay: Correlation of cytology and HPV status from 56,501 specimens

Journal of Molecular Diagnostics

Volumn 13, Issue 2, 2011, Pages 160-166

  Youens, Kenneth E ^a   Hosler, Gregory A ^b   Washington, Paula J ^b   Jenevein, E Patrick ^b   Murphy, Kathleen M ^b  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b ProPath   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS DNA;

ADULT; ARTICLE; CERVISTA HPV HR; CONDYLOMA ACUMINATUM; CONTROLLED STUDY; DIAGNOSTIC TEST; FEMALE; HUMAN; HYBRID CAPTURE 2; PAPANICOLAOU TEST; RETROSPECTIVE STUDY; UTERINE CERVIX CYTOLOGY; VIRUS DIAGNOSIS; WART VIRUS;

HUMAN PAPILLOMAVIRUS;

EID: 79952261871     PISSN: 15251578     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jmoldx.2010.11.016     Document Type: Article

References (32)

1. Schwarz E, Freese UK, Gissmann L, Mayer W, Roggenbuck B, Stremlau A, zur Hausen H: Structure and transcription of human papillomavirus sequences in cervical carcinoma cells. Nature 1985, 314:111-114 (Pubitemid 15142033)
2. Cogliano V, Baan R, Straif K, Grosse Y, Secretan B, El Ghissassi F: Carcinogenicity of human papillomaviruses. Lancet Oncol 2005, 6:204 (Pubitemid 40450709)
3. Meijer CJ, Snijders PJ, Castle PE: Clinical utility of HPV genotyping. Gynecol Oncol 2006, 103:12-17 (Pubitemid 44374721)
4. Muñoz N, Bosch FX, de Sanjosé S, Herrero R, Castellsagué X, Shah KV, Snijders PJ, Meijer CJ: Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med 2003, 348:518-527 (Pubitemid 36159887)
5. Apgar BS, Kittendorf AL, Bettcher CM, Wong J, Kaufman AJ: Update on ASCCP consensus guidelines for abnormal cervical screening tests and cervical histology. Am Fam Phys 2009, 80:147-155
6. Smith R, Cokkinides V, Brooks D, Saslow D, Brawley O: Cancer screening in the United States, 2010: a review of current American Cancer Society guidelines and issues in cancer screening. CA Cancer J Clin 2010, 60:99-119
7. ASCUS-LSIL Triage Study Group: Results of a randomized trial on the management of cytology interpretations of atypical squamous cells of undetermined significance. Am J Obstet Gynecol 2003, 188:1383-1392
8. Sherman ME, Lorincz AT, Scott DR, Wacholder S, Castle PE, Glass AG, Mielzynska-Lohnas I, Rush BB, Schiffman M: Baseline cytology, human papillomavirus testing, and risk for cervical neoplasia: a 10-year cohort analysis. J Natl Cancer Inst 2003, 95:46-52 (Pubitemid 36124295)
9. Wright TC, Massad LS, Dunton CJ, Spitzer M, Wilkinson EJ, Solomon D: 2006 Consensus guidelines for the management of women with abnormal cervical screening tests. J Low Genit Tract Dis 2007, 11: 201-222
10. Einstein MH, Martens MG, Garcia FA, Ferris DG, Mitchell AL, Day SP, Olson MC: Clinical validation of the Cervista HPV HR and 16/18 genotyping tests for use in women with ASC-US cytology. Gynecol Oncol 2010, 17:1-7
11. Ginocchio CC, Barth D, Zhang F: Comparison of the Third Wave Invader human papillomavirus (HPV) assay and the Digene HPV Hybrid Capture 2 assay for detection of high-risk HPV DNA. J Clin Microbiol 2008, 46:1641-1646 (Pubitemid 351657207)
12. Solomon D, Davey D, Kurman R, Moriarty A, O'Connor D, Prey M, Raab S, Sherman M, Wilbur D, Wright T, Young N: The 2001 Bethesda System: terminology for reporting results of cervical cytology. JAMA 2002, 287:2114-2119
13. Poljak M, Marin IJ, Seme K, Vince A: Hybrid Capture II HPV test detects at least 15 human papillomavirus genotypes not included in its current high-risk probe cocktail. J Clin Virol 2002, 25(suppl):3:S89-S97 (Pubitemid 35441020)
14. Johnson LR, Starkey CR, Palmer J, Taylor J, Stout S, Holt S, Hendren R, Bock B, Waibel E, Tyree G, Miller GC: A comparison of two methods to determine the presence of high-risk HPV cervical infections. Am J Clin Pathol 2008, 130:401-408
15. Schutzbank TE, Jarvis C, Kahmann N, Lopez K, Weimer M, Yount A: Detection of high-risk papillomavirus DNA with commercial Invader-technology-based analyte-specific reagents following automated extraction of DNA from cervical brushings in ThinPrep media. J Clin Microbiol 2007, 45:4067-4069 (Pubitemid 350274898)
16. Wong AK, Chan RC, Nichols WS, Bose S: Human papillomavirus (HPV) in atypical squamous cervical cytology: the Invader HPV test as a new screening assay. J Clin Microbiol 2008, 46:869-875 (Pubitemid 351379971)
17. Castle PE, Fetterman B, Poitras N, Lorey T, Shaber R, Kinney W: Five-year experience of human papillomavirus DNA and Papanicolaou test cotesting. Obstet Gynecol 2009, 13:595-600
18. Datta SD, Koutsky LA, Ratelle S, Unger ER, Shlay J, McClain T, Weaver B, Kerndt P, Zenilman J, Hagensee M, Suhr CJ, Weinstock H: Human papillomavirus infection and cervical cytology in women screened for cervical cancer in the United States, 2003-2005. Ann Intern Med 2008, 148:493-500
19. Franceschi S, Herrero R, Clifford GM, Snijders PJ, Arslan A, Anh PT, Bosch FX, Ferreccio C, Hieu NT, Lazcano-Ponce E, Matos E, Molano M, Qiao YL, Rajkumar R, Ronco G, de Sanjosé E S, Shin HR, Sukvirach S, Thomas JO, Meijer CJ, Muñoz N: Variations in the age-specific curves of human papillomavirus prevalence in women worldwide. Int J Cancer 2006, 119:2677-2684 (Pubitemid 44691325)
20. Dunne EF, Unger ER, Sternberg M, McQuillan G, Swan DC, Patel SS, Markowitz LE: Prevalence of HPV infection among females in the United States. JAMA 2007, 297:813-819 (Pubitemid 46333946)
21. Allen GL, Klobocista MM, Sugarman S, Gravel K, Feldman D, Schnatz PF: Prevalence of high-risk human papillomavirus in an inner-city population with atypical squamous cells of undetermined significance. J Low Genit Tract Dis 2009, 13:63-65
22. Thrall MJ, Russell DK, Facik MS, Yao JL, Warner JN, Bonfiglio TA, Giampoli EJ: High-risk HPV testing in women 30 years or older with negative Papanicolaou tests: initial clinical experience with 18-month follow-up. Am J Clin Pathol 2010, 33:894-898
23. Evans MF, Adamson CS, Papillo JL, St John TL, Leiman G, Cooper K: Distribution of human papillomavirus types in ThinPrep Papanicolaou tests classified according to the Bethesda 2001 terminology and correlations with patient age and biopsy outcomes. Cancer 2006, 106:1054-1064
24. Jacobs MV, Walboomers JM, Snijders PJ, Voorhorst FJ, Verheijen RH, Fransen-Daalmeijer N, Meijer CJ: Distribution of 37 mucosotropic HPV types in women with cytologically normal cervical smears: the age-related patterns for high-risk and low-risk types. Int J Cancer 2000, 87:221-227 (Pubitemid 30434349)
25. Sargent A, Bailey A, Almonte M, Turner A, Thomson C, Peto J, Desai M, Mather J, Moss S, Roberts C, Kitchener HC: Prevalence of type-specific HPV infection by age and grade of cervical cytology: data from the ARTISTIC trial. Br J Cancer 2008, 98:1704-1709 (Pubitemid 351684674)
26. Stoler MH, Schiffman M: Interobserver reproducibility of cervical cytologic and histologic interpretations: realistic estimates from the ASCUS-LSIL Triage Study. JAMA 2001, 85:1500-1505 (Pubitemid 32221899)
27. Kinney W, Stoler MH, Castle PE: Patient safety and the next generation of HPV DNA tests. Am J Clin Pathol 2010, 134:193-199
28. Wu R, Du H, Belinson S, Yang B, Qu X, Wang C, Wu R, Wang G, Yang G, Belinson JL: P-191: The Shenzhen Cervical Cancer Screening Trial II (SHENCCAST II). Presented at the 26th International Papillomavirus Conference; July 3-8, 2010; Montreal, QC, Canada
29. Baseman JG, Kulasingam SL, Harris TG, Hughes JP, Kivat NB, Mao C, Koutsky LA: Evaluation of primary cervical cancer screening with an oncogenic human papillomavirus DNA test and cervical cytologic findings among women who attended family planning clinics in the United States. Am J Obstet Gynecol 2008, 199:26.e1-26.e8
30. Knoepp SM, Kuebler DL, Wilbur DC: Resolution of equivocal results with the Hybrid Capture II High-Risk HPV DNA Test: a cytologic/histologic review of 191 cases. Diagn Mol Pathol 2007, 16:125-129 (Pubitemid 47329871)
31. Ko V, Tambouret RH, Kuebler DL, Black-Schaffer WS, Wilbur DC: Human papillomavirus testing using Hybrid Capture II with SurePath collection: initial evaluation and longitudinal data provide clinical validation for this method. Cancer, 2006, 108:468-474 (Pubitemid 46076966)
32. Siddiqi A, Spataro M, McIntire H, Akhtar I, Baliga M, Flowers R, Lin E, Guo M: Hybrid cCapture 2 human papillomavirus DNA testing for women with atypical squamous cells of undetermined significance: Papanicolaou results in SurePath and ThinPrep specimens. Cancer Cytopathol 2009, 117:318-325